Dasatinib Side Effects: What to Expect and When to Call Your Doctor

Dasatinib (Sprycel) is an effective treatment for Philadelphia chromosome-positive CML and ALL, but like all cancer medications, it comes with a range of side effects. Understanding what to expect—and knowing which symptoms are serious—helps you stay safe and continue therapy with confidence. This guide covers the most important side effects, what to watch for, and when to contact your oncologist immediately.

Common Side Effects of Dasatinib

These side effects occur in at least 10% of patients and are generally manageable:

• Fluid retention: Swelling in the hands, feet, or ankles is common. In some patients, fluid can build up in the chest cavity around the lungs (pleural effusion)—a more serious form discussed below.
• Diarrhea: One of the most frequently reported side effects. Mild diarrhea can often be managed with dietary adjustments. Tell your doctor if it's severe or persistent.
• Headache: Common, usually mild. Over-the-counter pain relievers can help, but check with your oncologist before taking NSAIDs (like ibuprofen), as they can increase bleeding risk.
• Fatigue: Feeling tired is common, especially in the first weeks of treatment. Rest when you need to and report significant fatigue to your oncologist.
• Nausea: Can occur at the start of treatment. Taking dasatinib with food may help reduce nausea.
• Skin rash: Mild rash is common and usually manageable. Severe or spreading rashes require immediate evaluation.
• Myelosuppression (low blood counts): Dasatinib can lower red blood cell, white blood cell, and platelet counts. This is monitored with regular blood tests. Low white cells increase infection risk; low platelets increase bleeding risk.

Serious Side Effects — Call Your Doctor Right Away

The following side effects are less common but require immediate medical attention:

• Pleural effusion (fluid around the lungs): Signs include shortness of breath, chest pain, or a dry cough. Pleural effusion is one of the most common serious side effects of dasatinib and may require a chest X-ray, dose reduction, or temporary treatment interruption.
• Pulmonary arterial hypertension (PAH): Increased blood pressure in the lungs. Symptoms include worsening shortness of breath, fatigue, and reduced exercise tolerance. This is a rare but serious complication that may be irreversible if not caught early.
• Severe bleeding: Dasatinib can cause serious bleeding, including GI bleeding. Seek emergency care for blood in stool, vomiting blood, or unexplained bruising.
• Cardiovascular events: After 5 years of follow-up in clinical trials, cardiac ischemic events occurred in about 3.9% of dasatinib-treated patients. Report chest pain, pressure, or discomfort immediately.
• Hepatotoxicity: Liver problems can occur. Watch for yellowing of skin or eyes (jaundice), dark urine, abdominal pain, or unusual fatigue. Liver function is monitored through blood tests during treatment.
• QT prolongation: Dasatinib can affect heart rhythm. Report palpitations, dizziness, or fainting to your doctor immediately.
• Signs of infection: Due to lowered white blood cell counts, infections are a risk. Fever (above 100.4°F / 38°C), chills, or unusual fatigue warrant a call to your oncologist right away.

Special Considerations for Bone Growth in Children

For pediatric patients (ages 1 and older) taking dasatinib, bone growth and development side effects have been reported in clinical trials after at least 2 years of treatment. These include delayed epiphyseal fusion, osteopenia, growth retardation, and gynecomastia. Pediatric patients on dasatinib should have bone growth and development monitored regularly.

Pregnancy and Fertility Warnings

Dasatinib can harm a developing fetus. Patients who can become pregnant—and male patients with partners who can become pregnant—must use effective contraception during treatment and for 30 days after the last dose. Do not breastfeed while taking dasatinib or for 2 weeks after the last dose. Dasatinib may also affect fertility in both men and women; discuss fertility preservation options with your oncologist before starting treatment if this is a concern.

How Are Side Effects Monitored?

Your oncologist will order regular CBC (complete blood count) and metabolic panels throughout treatment—typically every 2 weeks for the first 12 weeks, then monthly. You'll also have periodic ECG monitoring for QT prolongation. Always report new or worsening symptoms between scheduled visits. For information on medications that can worsen dasatinib side effects, see our guide on dasatinib drug interactions. If you need help finding your medication, medfinder can help locate it near you.